Related Experiment Video
Updated: Jul 14, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Coagulation studies in ulcerative colitis and Crohn's disease
Inflammatory bowel diseases like ulcerative colitis and Crohn's disease are linked to blood clotting abnormalities. Both conditions show increased clotting factors and platelet counts, alongside decreased antithrombin III levels.
Area of Science:
- Gastroenterology
- Hematology
- Internal Medicine
Background:
- Thromboembolic disease is a recognized complication of ulcerative colitis.
- Thromboembolic events are infrequently reported in Crohn's disease patients.
- The hemostatic balance in inflammatory bowel diseases requires further investigation.
Purpose of the Study:
- To investigate potential coagulation abnormalities in patients with ulcerative colitis and Crohn's disease.
- To compare coagulation profiles between inflammatory bowel disease patients and healthy controls.
Main Methods:
- A comparative study involving four groups: ulcerative colitis patients, Crohn's disease patients, patients with other diseases, and healthy controls.
- Analysis of platelet counts, coagulation factors (Factor V, Factor VIII), fibrinogen levels, and antithrombin III levels.
Main Results:
- Elevated platelet counts were observed in both ulcerative colitis and Crohn's disease groups.
- Increased levels of Factor V, Factor VIII, and fibrinogen were detected in both patient cohorts.
- Decreased antithrombin III levels were noted in patients with ulcerative colitis and Crohn's disease.
Conclusions:
- Coagulation abnormalities, including a prothrombotic state, are present in both ulcerative colitis and Crohn's disease.
- These findings suggest a potential link between inflammatory bowel diseases and an increased risk of thromboembolic events.
- Further research is warranted to elucidate the clinical implications of these hemostatic changes.
More Related Videos
09:42Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation
Published on: August 26, 2014
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease IV: Clinical Manifestations